HAO TIAN INTL (01341) completed the placement of approximately 249 million shares, raising approximately 28.7 million Hong Kong dollars.
Haotian International Investment (01341) announced that it has completed the placement of approximately 249 million shares on December 10, 2025, at a price of 0.118 Hong Kong dollars per share, raising a net amount of approximately 287 million Hong Kong dollars for the expansion of its licensed corporation financing and margin financing business.
HAO TIAN INTL (01341) announced that it has completed the placement of approximately 249 million shares on December 10, 2025 at a price of HK$0.118 per share, raising a net amount of about HK$28.7 million. The proceeds will be used for the expansion of licensed financial institution financing and margin financing business.
Related Articles
Montage Technology (688008.SH) successfully obtained approval from the China Securities Regulatory Commission for its overseas listing of shares (H shares).
Shareholders Hangzhou Haoyue and Hangzhou Xintou plan to reduce their holdings by no more than 3% in Meinian Onehealth Healthcare Holdings (002044.SZ).
BIOCYTOGEN-B (02315) issued 47.5 million A-shares on December 10th.
Montage Technology (688008.SH) successfully obtained approval from the China Securities Regulatory Commission for its overseas listing of shares (H shares).
Shareholders Hangzhou Haoyue and Hangzhou Xintou plan to reduce their holdings by no more than 3% in Meinian Onehealth Healthcare Holdings (002044.SZ).
BIOCYTOGEN-B (02315) issued 47.5 million A-shares on December 10th.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
